GenEdit: GenEdit Announces Series A Financing and Provides Research Update at TIDES 2021
GenEdit, Inc today announced that it has closed a $26 million Series A financing.
Read full article »
GenEdit is a California-based biotechnology company that develops and commercializes curative therapies for the treatment of genetic diseases.
Read more